PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1663541
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1663541
Medical Imaging Phantoms Market size was valued at US$ 185.5 Million in 2024, expanding at a CAGR of 6.10% from 2025 to 2032.
Medical imaging phantoms are specially made items that enable medical imaging device calibration, testing, training, and research. They are essential to the healthcare system. They are essential for equipment maintenance and quality control because they mimic the reactions of human tissue in imaging systems such as MRIs, CT scans, and ultrasounds, allowing for accurate diagnosis. The use of medical imaging phantoms in clinics, hospitals, and research facilities has increased because of the increasing need for high-quality imaging and compliance with strict regulatory requirements. The increase in the incidence of chronic diseases like cancer and HIV is one of the main reasons anticipated to propel the growth of the medical imaging phantoms market during the forecast period. Additionally, the market for medical imaging phantoms is expanding due to rising accident rates and the need for more sophisticated screening. However, it is also predicted that the increase in cost-related concerns may hinder the market expansion for medical imaging phantoms during the forecast period.
Medical Imaging Phantoms Market- Market Dynamics
Increased incidence of chronic diseases
The market for medical imaging phantoms is expanding due in large part to the increased incidence of chronic diseases such as cancer, heart disease, neurological conditions, and long-term respiratory conditions. These disorders require regular, precise diagnosis, care, and imaging monitoring. Globally, chronic non-communicable diseases (NCDs) are the leading cause of death and disability, according to the World Health Organization (WHO). Approximately 71% of all deaths globally are caused by chronic illnesses, which kill 41 million people each year. Additionally, cardiovascular diseases account for 17.9 million deaths annually, making them the primary cause of chronic disease-related deaths. 9.3 million people die from cancer each year, making it the second most common cause. Each year, diabetes, including deaths from kidney disease associated with diabetes, causes 2.0 million deaths, compared to 4.1 million deaths from chronic respiratory diseases. These illnesses add to the increasing need for phantoms and medical imaging devices, which are essential for providing accurate and reliable diagnoses and treatment outcomes.
Medical Imaging Phantoms Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.10% over the forecast period (2025-2032)
Based on application segmentation, the calibration & quality assurance were predicted to show maximum market share in the year 2024
Based on end use segmentation, hospitals were the leading segment in 2024
On the basis of region, North America was the leading revenue generator in 2024
The Global Medical Imaging Phantoms Market is segmented on the basis of Application, Product, End Use, and Region.
On the basis of product, the market is segregated into CT (Computed Tomography) Phantoms, X-ray Phantoms, Ultrasound Phantoms, MRI (Magnetic Resonance Imaging) Phantoms, Nuclear Medicine Phantoms, and Others. In 2024, the market was dominated by the X-ray phantoms category. In medical imaging, X-ray phantoms are mathematical or physical models that mimic the characteristics of the human body. In many facets of medical imaging research, such as equipment calibration, quality control, and teaching, phantoms are indispensable. By allowing researchers and experts to accurately modify imaging parameters like exposure settings, contrast, and resolution, phantoms improve the quality of X-ray images. Phantasms are used by researchers to solve radiation exposure concerns, especially in the area of medical imaging. Using these phantoms, strategies for reducing radiation dosage without sacrificing image quality are developed and tested. Due to the extensive use and affordability of X-ray imaging in many different sectors, such as orthopaedics, dentistry, mammography, and angiography, the X-ray category maintained the largest market share.
Based on end use, the market is divided into Hospitals, Clinics, and Others. In 2024, the hospitals category held a dominant market share. Hospitals are the biggest buyers of phantoms and medical imaging equipment since they do a lot of diagnostic imaging procedures. The market benefits from the expanding hospital population. There were 3,336 urban community hospitals, 3,453 community hospitals within a system, and 1,805 rural community hospitals in the United States in 2019, according to the 2021 American Hospital Association Annual Survey. Additionally, in 2019, there were approximately 36,241,815 hospital admissions overall across all US hospitals. Furthermore, effective reimbursement programs in hospitals in particular countries across the world that lessen patients' financial burdens help to grow the hospital market.
Medical Imaging Phantoms Market- Geographical Insights
In 2024, North America held a dominant position in the global market for Medical Imaging Phantoms due to a number of factors. The prevalence of chronic illnesses, the extensive use of phantoms and sophisticated medical imaging equipment, the sophistication of healthcare facilities and infrastructure, and the availability of qualified and experienced personnel are some of these variables. According to the American Heart Association, cardiovascular disease (CVD) continued to be the leading cause of death in the US in 2020, accounting for 928,741 fatalities. Additionally, North America benefits from a high prevalence of chronic diseases, significant investments in research and development, and an advanced healthcare infrastructure.
However, throughout the projected period, the Asia-Pacific region is anticipated to see the fastest CAGR. Increased healthcare spending, population growth, urbanization, rising incomes, and greater knowledge of health issues are all contributing to the region's healthcare sector's notable expansion. Between 2000 and 2019, China's health spending increased significantly, from less than 500 billion yuan to over 6.5 trillion yuan. Furthermore, China spent more than 8.5 trillion yuan on healthcare overall in 2022. Additionally, a number of disorders, such as cancer, heart disease, diabetes, and infectious diseases, are becoming more common in the area, requiring quick and effective diagnosis and treatment. According to the WHO South-East Asia Region, there were about 1.4 million cancer-related deaths and 2.2 million new cases of cancer in 2020. These deaths represented more than 10% of all deaths in the area. Because they improve the standard and accessibility of healthcare services, these characteristics create a significant demand for phantoms and medical imaging equipment.
Among the leading businesses in the Medical Imaging Phantoms market are BARTEC Top Holding GmbH, IBA Worldwide, Kyoto Kagaku Co., Ltd., Gold Standard Phantoms, PTW Freiburg GmbH, and others. The development of sophisticated 3D-printed phantoms, collaborations for affordable imaging, and increased R&D expenditure are examples of strategic initiatives that are intended to increase diagnostic precision and accessibility in underprivileged regions. For instance, Philips introduced the AI-enabled CT 5300 at #ECR2024 in February 2024, improving diagnostic efficiency and capabilities and driving improvements in medical imaging phantoms for precise patient evaluations and complicated cardiac cases.
Recent Development
December 2024: With the addition of a 70-centimeter bore scanner built for patient comfort, sustainability, improved picture quality, and automated workflows, Siemens Healthineers extended the 1.5 Tesla Magnetom Flow MRI platform.
July 2024: RSD Radiology Support Devices stated that Multimodality Phantoms, which will improve accuracy and dependability in medical diagnostics across many imaging modalities, such as CT, MRI, and X-ray, would soon be available.
June 2024: With the production of multilayer plastic manifolds scheduled to start in 2025, Festo purchased Carville's process technologies and production facilities, strengthening our creative solutions in medical and laboratory automation.